Some back symptoms need medical care before any purchase

New weakness or bladder trouble needs prompt care

Get prompt help if you suddenly can't control your bladder or bowels, especially when your inner thighs or groin also feel numb. A dragging foot or growing leg weakness also needs an exam now. Don't stay home to see whether weakness passes because those signs can't wait.

Fever with new back soreness may come from an illness. A hard fall deserves care, especially if your bones are weak. Even a smaller fall may matter as you grow older, and you don't have to judge that alone.

Tell the doctor about past cancer, a recent illness, or a recent back procedure. Severe new soreness with belly or side symptoms may not come from your spine. Urgent care or a hospital may be the safer place. Don't take chances.

A scan doesn't prove which spot is sore

Scans often show worn discs or bulges in people whose backs don't hurt. A scan helps only when the worn area lines up with where you hurt and with weakness or numbness found during the exam. One scan finding shouldn't make a doctor choose a procedure because it may have nothing to do with your ache.

A useful visit checks your strength, feeling, and movement. The person examining you will ask where the soreness travels and what brings it on. Sleep, work, falls, and past care also matter because those details help explain the scan.

If a treatment aims at one small area, ask which exam finding points there. Also ask what finding would make the clinic decide that area isn't the cause. You don't need a speech full of medical terms. A plain answer will do.

A careful plan includes a stopping point

Before paying, decide which useful change you hope to see. It could be easier walking, better sleep, or less trouble getting dressed. Ask when you'll check for that change because care shouldn't drift into repeated spending.

Among the choices you may hear, QC Kinetix offers non-surgical regenerative treatments, including a concentrated PRP shot prepared by spinning your blood and given by a trained health worker after an exam. Ask whether a doctor, nurse, or another health worker will give the care. Also mention any medicine that affects bleeding, and don't stop a prescribed pill on your own.

Sources

1. A systematic review of 14 diagnostic studies evaluating 53 red flags found that MOST red flags endorsed in guidelines change the probability of fracture or malignancy almost not at all. The ones that do carry weight for fracture are a visible contusion or abrasion (62% post-test probability), prolonged corticosteroid use (33%), severe trauma (11%) and older age (9%); for malignancy it is a history of malignancy (33%). Probability of fracture rises to 90% when multiple red flags are present together.

   Downie A, Williams CM, Henschke N, et al. — Red flags to screen for malignancy and fracture in patients with low back pain: systematic review.. BMJ, 2013. DOI: 10.1136/bmj.f7095.

2. The Lancet low back pain series states that for nearly all people with low back pain it is NOT possible to identify a specific nociceptive cause; only a small proportion have a well-understood pathological cause such as vertebral fracture, malignancy or infection. Most new episodes recover quickly, recurrence is common, and in a small proportion the pain becomes persistent and disabling - with initial high pain intensity, psychological distress and pain at multiple body sites raising that risk.

   Hartvigsen J, Hancock MJ, Kongsted A, et al. — What low back pain is and why we need to pay attention.. The Lancet, 2018. DOI: 10.1016/S0140-6736(18)30480-X.

3. A systematic review of 33 studies imaging 3,110 people WITHOUT back pain found disc degeneration in 37% of 20-year-olds rising to 96% of 80-year-olds, disc bulges in 30% rising to 84%, disc protrusions in 29% rising to 43%, and annular fissures in 19% rising to 29%. The authors conclude that many degenerative imaging features are part of normal ageing and unassociated with pain.

   Brinjikji W, Luetmer PH, Comstock B, et al. — Systematic literature review of imaging features of spinal degeneration in asymptomatic populations.. American Journal of Neuroradiology, 2015. DOI: 10.3174/ajnr.A4173.

4. The 2025 ASIPP regenerative-therapy guideline for chronic low back pain - written by the specialty society that performs these procedures - grades the evidence as Level III (fair) for intradiscal PRP, Level III (fair) for intradiscal bone marrow concentrate, Level III (fair) for epidural PRP, Level IV (limited) for facet joint PRP and MSC injections, Level IV (limited) for sacroiliac joint PRP, and very low for functional-spine-unit injections. All 19 recommendations are consensus-based rather than evidence-driven, the panel names the scarcity of high-quality studies as the primary limitation, and it states that most of these therapies are not covered by commercial insurance.

   Manchikanti L, Navani R, Navani A, et al. — Comprehensive Evidence-Based Guidelines for Regenerative Therapies in the Management of Chronic Low Back Pain: 2025 Update from the American Society Of Interventional Pain Physicians (ASIPP).. Pain Physician, 2025.

5. The FDA states verbatim that stem cell products, stromal vascular fraction, umbilical cord blood, Wharton's jelly, amniotic fluid and exosome products have NOT been 'approved for the treatment of any orthopedic condition, such as osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain, or shoulder pain.' No stem cell product is approved in the United States for any orthopedic use: the only ones with FDA approval at all are blood-forming cells derived from umbilical cord blood, approved solely for disorders of blood production, and there are currently no FDA-approved exosome products.

   U.S. Food and Drug Administration — Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes.. FDA.gov, 2025.

6. The Cochrane review of exercise therapy for chronic low back pain pooled 249 trials and found moderate-certainty evidence of a clinically important 15.2-point pain reduction (0-100 scale) versus no treatment, usual care or placebo. The effect on functional limitations was 6.8 points, which did NOT meet the review's own threshold for a minimal clinically important difference, and adverse effects were mostly minor muscle soreness.

   Hayden JA, Ellis J, Ogilvie R, Malmivaara A, van Tulder MW — Exercise therapy for chronic low back pain.. Cochrane Database of Systematic Reviews, 2021. DOI: 10.1002/14651858.CD009790.pub2.

7. The RESTORE trial randomised 492 people with chronic disabling low back pain across 20 primary-care physiotherapy clinics to usual care, cognitive functional therapy, or cognitive functional therapy with movement-sensor biofeedback. Both therapy arms produced a 4.6-point improvement on the 24-point Roland Morris Disability Questionnaire versus usual care at 13 weeks, with similar effect sizes still present at 52 weeks and substantially lower societal costs. Adding the sensor added nothing.

   Kent P, Haines T, O'Sullivan P, et al. — Cognitive functional therapy with or without movement sensor biofeedback versus usual care for chronic, disabling low back pain (RESTORE): a randomised, controlled, three-arm, parallel group, phase 3, clinical trial.. The Lancet, 2023. DOI: 10.1016/S0140-6736(23)00441-5.